Work

High resolution nanobody footprinting of cortactin in cancer cell invasion

Year: 2018
Type: dissertation
Abstract: Tumor development is characterized by uncontrolled cell growth due to genetic and environmental factors.Cancer mortality is mainly caused by the spread of cancer cells from the primary tumor to other parts of the body.Cancer cells break away from the original tumor, invade the surrounding tissue, enter blood or lymph vessels, and extravasate at distant sites to form secondary tumors, or metastases.During the different stages of metastasis, the actin cytoskeleton is hijacked by cancer cells to increase their motility.Different types of actin-mediated cellular protrusions assist in cancer cell motility including lamellipodia and filopodia at the leading edge, and proteolytic active invadopodia at the ventral side of invading cells.In physiological conditions, the actin cytoskeleton is essential for the maintenance of cell shape, response to environmental changes and protrusive force during cell movement.The actin binding, multidomain protein cortactin is one of the many regulators of the shape and dynamics of actin filaments: cortactin binds to and activates the Arp2/3 complex, leading to the formation of a branched actin network, and stabilizes actin filaments.The cortactin gene is overexpressed in different cancer types, and is associated with increased invadopodia formation, cell motility, invasion and metastasis formation.The objective of this thesis is to delineate the role of different cortactin domains during invadopodia formation and function.Three different cortactin nanobody sets are described, each targeting a different cortactin region: two NTA nanobodies against the N-terminal acidic (NTA) domain, two FHP nanobodies targeting the central regions (the F-actin binding repeats, helical and proline rich domain), and one SH3 nanobody against the SH3 domain.The NTA and FHP nanobody sets were generated and characterized, and their effect on invadopodia and invasion was compared to the previously characterized SH3 nanobody.Additionally, the interaction of the SH3 nanobody with the SH3 domain was studied in more detail.In the first section, two nanobodies against the NTA domain are characterized and compared with a nanobody that targets the SH3 domain.The NTA nanobodies both prevent cortactin-mediated Arp2/3 activation (Table 1).The two nanobody sets, i.e. the NTA and SH3 nanobodies, similarly decrease invadopodia formation, protease secretion, matrix degradation and protease-dependent invasion, illustrated by protease inhibitor GM6001.One NTA nanobody also inhibits the cortactin-Arp2/3 complex interaction and reduces invadopodium stability.Interestingly, inhibition of Arp2/3 complex activation, either by cortactin NTA nanobodies or by Arp2/3 inhibitor CK-666, causes a larger decrease in invadopodia formation in head and neck squamous cell carcinoma versus breast cancer cells.This suggests that invadopodia formation and composition is a cell type-specific process.xiv
Institution: Ghent University
Language: English
Subfield: Cell Biology
Open Access status: green
OpenAlex ID: W2970261930
Cites: 659
Cited by:
Related to: 10